B

Bioton SA
WSE:BIO

Watchlist Manager
Bioton SA
WSE:BIO
Watchlist
Price: 2.81 PLN -3.77% Market Closed
Market Cap: 241.3m PLN
Have any thoughts about
Bioton SA?
Write Note

Bioton SA
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bioton SA
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
B
Bioton SA
WSE:BIO
Change in Working Capital
zł3.2m
CAGR 3-Years
N/A
CAGR 5-Years
-23%
CAGR 10-Years
N/A
M
Mabion SA
WSE:MAB
Change in Working Capital
zł13.4m
CAGR 3-Years
-13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
R
Read Gene SA
WSE:RDG
Change in Working Capital
-zł348.3k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genomed SA
WSE:GEN
Change in Working Capital
zł422.4k
CAGR 3-Years
-20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
U
Urteste SA
WSE:URT
Change in Working Capital
-zł56k
CAGR 3-Years
28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Synthaverse SA
WSE:SVE
Change in Working Capital
-zł3.4m
CAGR 3-Years
21%
CAGR 5-Years
N/A
CAGR 10-Years
9%
No Stocks Found

Bioton SA
Glance View

Market Cap
241.3m PLN
Industry
Biotechnology

BIOTON SA engages in the manufacture and production of medicine and pharmaceutical substances. The company is headquartered in Warsaw, Woj. Mazowieckie and currently employs 371 full-time employees. The company went IPO on 2005-03-16. The firm is engaged in research, development and wholesale trade of pharmaceutical and biotechnological products. The firm's portfolio consists of oral hypoglycemic drugs (metformin and glimepride) as well as recombinant human insulin in pharmaceutical substance form and for injections. Additionally, the Company provides advertising services. As of December 31, 2011, the Company formed a capital group and operated through its subsidiaries, including BIOTON TRADE Sp. z o.o., Mindar Holdings Ltd, Germonta Holdings Ltd, Tricel SA, SciGen Ltd and BioPartners Holdings AG, among others. On June 12, 2014, it sold a 50% stake in Copernicus Sp. z o.o.

BIO Intrinsic Value
2.83 PLN
Undervaluation 1%
Intrinsic Value
Price
B

See Also

What is Bioton SA's Change in Working Capital?
Change in Working Capital
3.2m PLN

Based on the financial report for Sep 30, 2024, Bioton SA's Change in Working Capital amounts to 3.2m PLN.

What is Bioton SA's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
-23%

Back to Top